Bide Pharmatech Balance Sheet Health
Financial Health criteria checks 6/6
Bide Pharmatech has a total shareholder equity of CN¥2.0B and total debt of CN¥58.4M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are CN¥2.4B and CN¥354.2M respectively. Bide Pharmatech's EBIT is CN¥92.2M making its interest coverage ratio -4.2. It has cash and short-term investments of CN¥1.2B.
Key information
2.9%
Debt to equity ratio
CN¥58.39m
Debt
| Interest coverage ratio | -4.2x |
| Cash | CN¥1.17b |
| Equity | CN¥2.00b |
| Total liabilities | CN¥354.19m |
| Total assets | CN¥2.35b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688073's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥316.0M).
Long Term Liabilities: 688073's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥38.2M).
Debt to Equity History and Analysis
Debt Level: 688073 has more cash than its total debt.
Reducing Debt: 688073's debt to equity ratio has reduced from 22.2% to 2.9% over the past 5 years.
Debt Coverage: 688073's debt is well covered by operating cash flow (284.4%).
Interest Coverage: 688073 earns more interest than it pays, so coverage of interest payments is not a concern.